Pfizer Inc (NYSE: PFE)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/01/2023
Closing price: 28.91
Support price level: | N/A |
Resistance price level: | $31.13 |
Relative strength index (14-day RSI) | 45.3 |
Beta | 0.39 |
- PFE is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -42.3 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- PFE is one of this month's worst performers with a return of -5.2%, underperforming 90 percent of stocks in the S&P-100.
- Down 5.2 percent, PFE is one of this week's biggest decliners.
- The price of this low-beta stock is expected to increase by 0.39% for every 1% increase in the S&P-500.
- Volatility is forecast to rise over the next month.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$28.91 | $54.48 | 0.0% |
200 day | 50 day | 20 day | 10 day |
$36.37 | $31.29 | $30.11 | $30.03 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
26.8% | 26.7% | 22.8% | 29.9% |
- 6.2% in the next week.
- 16.9% in the next month.
- 44.3% in the next year.
Company news for Pfizer Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks